Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial

ABSTRACT Background Despite the popularity of a ketogenic diet, no randomized, controlled trials have evaluated its efficacy on metabolic dysfunction‐associated steatotic liver disease (MASLD) progression. Methods We conducted an 8‐week, open‐label, randomized controlled trial involving 24 patients...

Cijeli opis

Bibliografski detalji

Glavni autori:	Sakkarin Chirapongsathorn, Wiwit Rintaravitoon, Bhagawat Tangjaturonrasme, Samitti Chotsriluecha, Yanisa Pumsutas, Achariya Kanchanapradith, Sombat Treeprasertsuk
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-01-01
Serija:	JGH Open
Teme:	ketogenic diet MASLD metabolic dysfunction‐associated steatotic liver disease
Online pristup:	https://doi.org/10.1002/jgh3.70099
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!